HANNAH RUDOLPH: Open Payments
NPI 1003540204 · GREENWOOD, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,160 in 209 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $1,269 · 2025 $3,160
Food & beverage: $2,982Education: $178
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 10 | $413 |
| ABBVIE INC. | 29 | $381 |
| UCB, Inc. | 25 | $327 |
| Amgen Inc. | 17 | $293 |
| Janssen Biotech, Inc. | 16 | $280 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 16 | $225 |
| Regeneron Healthcare Solutions, Inc. | 18 | $222 |
| Novartis Pharmaceuticals Corporation | 22 | $198 |
| E.R. Squibb & Sons, L.L.C. | 7 | $187 |
| LEO Pharma Inc. | 21 | $181 |
Products named: NEMLUVIO, DUPIXENT, Bimzelx, Otezla, TREMFYA, SKYRIZI, Sotyktu, RINVOQ.
Industry payments across IN — which companies pay providers there.
